However, in subjects with moderate liver impairment, adverse reactions such as decreased platelet count (50%) and hypoalbuminemia (25%) had relatively higher occurrence rates, which may be related to the baseline thrombocytopenia and lower albumin levels in patients with moderate liver impairment. Here, ALB is linked to Thrombocytopenia.